<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03844672</url>
  </required_header>
  <id_info>
    <org_study_id>00081069</org_study_id>
    <secondary_id>K01DA047433</secondary_id>
    <nct_id>NCT03844672</nct_id>
  </id_info>
  <brief_title>Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns</brief_title>
  <official_title>Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns Among</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to understand how different e-cigarettes influence their
      likeability and use among current smokers who try using e-cigarettes. Participants will
      receive an e-cigarette to sample over a three week period. During this time period they will
      complete daily electronic diaries and weekly lab visits. The results from this information
      will help understand how different types of e-cigarettes are likely to influence cigarette
      and e-cigarette use.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Cigarettes Per Day</measure>
    <time_frame>up to 3 weeks</time_frame>
    <description>Participants complete daily electronic diaries reporting the number of cigarettes smoked each day on a continuous scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average Number of E-cigarette Puffing Episodes</measure>
    <time_frame>up to 3 Weeks</time_frame>
    <description>Participants complete daily electronic diaries reporting the number of e-cigarette puffing episodes each day on a continuous scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Choices to Smoke Cigarette in Lab Setting</measure>
    <time_frame>Week 3</time_frame>
    <description>Participants complete lab-based choice task at Week 3 visit in which they choose between smoking conventional cigarette and e-cigarette over 10 trials. Outcome is number of times each participant chooses to smoke conventional cigarette.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Smoking</condition>
  <condition>Tobacco Use</condition>
  <arm_group>
    <arm_group_label>Low Concentration / Low Power</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant will receive an e-liquid with a low nicotine concentration and an e-cigarette with a low power for three weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Concentration / High Power</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant will receive an e-liquid with a low nicotine concentration and an e-cigarette with a high power for three weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Concentration / Low Power</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant will receive an e-liquid with a high nicotine concentration and an e-cigarette with a low power for three weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Concentration / High Power</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant will receive an e-liquid with a high nicotine concentration and an e-cigarette with a high power for three weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Power</intervention_name>
    <description>Participants will receive a low power e-cigarette to use for 3 weeks</description>
    <arm_group_label>High Concentration / Low Power</arm_group_label>
    <arm_group_label>Low Concentration / Low Power</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High Power</intervention_name>
    <description>Participants will receive a high power e-cigarette to use for 3 weeks</description>
    <arm_group_label>High Concentration / High Power</arm_group_label>
    <arm_group_label>Low Concentration / High Power</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low Concentration</intervention_name>
    <description>Participants will receive a low concentration e-liquid to use for 3 weeks</description>
    <arm_group_label>Low Concentration / High Power</arm_group_label>
    <arm_group_label>Low Concentration / Low Power</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High Concentration</intervention_name>
    <description>Participants will receive a high concentration e-liquid to use for 3 weeks</description>
    <arm_group_label>High Concentration / High Power</arm_group_label>
    <arm_group_label>High Concentration / Low Power</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria include

          -  adults who have been smoking daily

          -  interested in using e-cigarettes

          -  who have a smartphone that can receive text messages and access to the internet or has
             an e-mail account that they check daily

        Exclusion criteria include

          -  minimal prior e-cigarette use

          -  use of tobacco products other than cigarettes

          -  current use of cessation medications

          -  pregnant, trying to become pregnant, or breastfeeding,

          -  recent history of cardiovascular distress in the last three months (e.g., arrhythmia,
             heart attack, stroke, uncontrolled hypertension),

          -  household member currently enrolled in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tracy Smith, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tracy Smith, PhD</last_name>
    <phone>843-792-5164</phone>
    <email>smithtra@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matt Carpenter, PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Smith, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>February 14, 2019</study_first_submitted>
  <study_first_submitted_qc>February 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2019</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Tracy Smith</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

